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Answering the Initial 20 Questions on COVID-19 (January-February 2020) 
Igor Rudan 
Centre for Global Health, Usher Institute for Population Health Sciences and Informatics, 
The University of Edinburgh, Scotland, UK 
In response to COVID-19 pandemic, the “Journal of Global Health” will publish regular 
editorials answering the questions related to the pandemic that raised most interest during 
the preceding period. These editorials will be written in a popular style and aimed at wide 
audience. They will be based on the best available evidence at the time. This is the first 
editorial, completed on March 7th, 2020, and answering the 20 questions that arose during 
January and February 2020. 
In this text, I’ve summarised the issues that I see most often lead to misunderstandings or 
cause confusion about the new COVID-19 pandemic. I’ve offered all of these answers from 
the perspective of a scientist who has been involved in this field internationally for two 
decades. My answers seek to give a view that is scientifically based on the data which is 
currently available about this pandemic, as well as the experience of previous epidemics and 
pandemics caused by respiratory viruses. 
However, I’d like to emphasise that there is still a number of ambiguities at the time of 
writing this article regarding the new COVID-19 pandemic. Scientists are closely monitoring 
its development and gathering new evidence, which is why this pandemic needs to be taken 
seriously and adhered to by all public health experts. In the event of this situation 
worsening, one should also be prepared for preventive public health measures such as 
avoiding public gatherings and quarantines at home. 
1. Is this one of “those” infectious diseases that will decimate us and which will take its 
place in history? 
The history of the genus Homo and the dozen human species we know of today through 
archaeological excavation was determined by the fight against infectious diseases. It’s likely 
that the species that are no longer around today are largely extinct due to the spread of 
infectious diseases [1]. We should be happy that we no longer live in the times of great 
epidemics and pandemics that once decimated our species. A huge number of people died 
during their childhood or youth [1]. 
The most severe mediaeval infections killed up to every third person. Before the discovery 
of the microscope, people couldn't even know why it was happening to them. No one 
thought that tiny, invisible, living microbes could cause these diseases. People assumed that 
some heavenly punishment for their sins had come upon them. We should, therefore, be 
grateful that we’re living in the age of this advancement of science and medicine [1]. 
Since 1940, many bacterial diseases have begun to be controlled by antibiotics, and since 
1960, many viral and bacterial diseases have had vaccines developed for them [1]. 
Unfortunately, we don't have a vaccine for all infectious diseases. As we see in the example 
of this pandemic, new viruses continue to transfer from other species to us because history 
hasn’t ended with the advent of our generation. Instead, it just continues, but this pandemic 
certainly doesn’t look like it will “decimate” us. 
2. Could science have anticipated the COVID-19 pandemic? 
It could have, because this is already the seventh coronavirus to try to make itself at home 
within the human population [2]. It is trying to adapt to us and use us as its reservoir. 
Specifically, we exist together with this virus on a small blue-brown planet in a vast dark 
universe. We share it with tens of millions of other species. They all strive to barely survive. 
More than 99%of all species that have ever existed on Earth have failed to survive to this 
day [1]. That is why viruses constantly transfer themselves to new species and thus expand 
their reservoirs. They must choose the winning species because they can’t reproduce on 
their own. Their survival depends on the survival of the species that is their reservoir [3]. 
Humans are currently an interesting potential viral reservoir. We’re expanding rapidly in 
population size - from about a billion-and-a-half individuals, we’ve grown to about seven-
and-a-half-billion in the last 130 years alone [1]. In doing so, we’re conquering new 
territories, clearing forests, draining wetlands, hunting for pleasure and reducing overall 
biodiversity [1]. This is making it increasingly difficult for others to survive, while there are 
more and more of us. Fortunately for us all, the first four human-adapted coronaviruses 
were merely the cause of common colds [2]. No-one considered the four of them a serious 
threat to public health. 
3. Were SARS and MERS a serious threat? 
SARS (severe acute respiratory syndrome) and MERS (Middle Eastern acute respiratory 
syndrome) were a real surprise for scientists and experts. These were further respiratory 
viruses from the coronavirus family, the fifth and sixth that managed to infect humans. 
Surprisingly, instead of colds, they were able to cause very severe, fatal pneumonia [2]. In 
addition, the death rate among those infected with both diseases was truly frightening. 
SARS killed one-in-ten infected while MERS killed one-in-three. Both could have caused a 
horrible amount of human deaths if they spread to the world's entire population [2]. 
The coronavirus that caused SARS had its reservoir in bats, which hibernate in caves in 
winter. This is the time of the year when hardly anyone hunts or consumes bats. However, 
SARS managed to infect an animal from the cat family, a civet. From a civet it was then also 
contracted by a man, a farmer in Guangdong province, in late 2002. SARS then spread to 
more than twenty countries and infected more than 8,000 people, with every tenth infected 
person dying from the disease. It was the fifth human coronavirus, but it was the first to kill 
humans [2]. 
Ten years later, in 2012, the MERS coronavirus appeared in Saudi Arabia. It was passed on 
to humans from the camels in the desert. It has also spread to more than twenty countries, 
infecting about 2500 people and every third infected person died [2]. So, both SARS and 
MERS had a really scary case-fatality rate. The advent of MERS showed us that SARS was not 
an isolated incident with a coronavirus that we could just forget about, but that 
coronaviruses have become the most significant potential biological threat to our species. If 
SARS or MERS had spread around the world and infected billions of people, they would have 
caused a catastrophe unlike any other in the modern history of humans. 
4. How were MERS and SARS dealt with so swiftly, considering the fact that they were so 
dangerous? 
In those two cases, we were actually very lucky. Essentially, an entirely new virus that tries 
to transfer over to the human species can spread among humans in three basic ways. Each 
of these three ways informs our strategies for epidemic surveillance and dealing with the 
epidemic. Once the virus enters the human body, it begins to multiply in the kind of 
specialised cells that it has the ability to bind to. In the case of coronaviruses, these are the 
cells of the respiratory system. The virus multiplies in them by “hacking” their cellular 
genetic code and using their “machinery” to build its own proteins [2]. 
This multiplication of the virus eventually destroys the infected cells. That is the reason for 
the eventual development of the symptoms that are characteristic of respiratory infections 
such as a sore throat and cough. In the first mode of the spread, the virus will “jump” from 
the infected person to unaffected people only after the onset of those symptoms. 
Such an epidemic is the easiest to control and contain. That is because the sick person is 
soon confined to bed and no longer leaves home. Therefore, the virus can mainly spread to 
their household members. This also makes it relatively easy to identify everyone who was in 
contact with the person after the onset of symptoms. Those people can then be placed in 
isolation quite easily. We were fortunate that both SARS and MERS spread to other people 
only after the onset of the symptoms of the disease. This is why we were able to suppress 
the epidemics by isolating those infected and all their contacts after the onset of the 
symptoms. This is quite likely the most important reason why SARS and MERS didn't 
manage to kill remarkably large number of people [2]. 
It is much more difficult to contain an epidemic if the virus spreads from infected to healthy 
people during the period of the so-called incubation. This period lasts from the entry of the 
virus into the body until the onset of the first symptoms [3]. In such case infected persons 
can transmit the virus by contact to a significantly larger number of people in the days 
before they get any symptoms. That seems to be the situation with this new COVID-19 
pandemic. But even then, it is at least possible for every new patient to determine from 
whom they contracted the infection. Namely, all newly diagnosed cases had to meet an 
existing and known case in the past. 
This allows epidemiologists to follow the entire chain of movement of the virus from person 
to person. Due to this favourable circumstance, intensive isolation measures of all those 
who were in contact with those already infected can significantly slow down the spread of 
the virus. This was done in Wuhan. That's why “test-trace-isolate”, as the first line of 
defence, and quarantines as the ultimate response, both represent a justified containment 
strategy when people are infectious for others during incubation period. Both approaches 
will slow down and contain the epidemic if applied properly. 
A nightmare scenario for any epidemiologist, however, is a third possibility for the virus to 
spread. In such a variant, people become infected and transmit the virus, but they 
themselves never show any symptoms. Scientists are currently looking for such possible 
spreads of contagion with this new COVID-19 pandemic. That is the reason why such 
possible persons are occasionally mentioned in the media in high-profile articles. 
Namely, because of such infected people, cases are beginning to emerge among the 
population that can’t be linked to any of the already infected people. When people are 
circulating in the population without symptoms but passing the virus on to others, it’s very 
difficult for epidemiologists to do anything to prevent it from spreading among all humans. 
Such an epidemic has the potential to spread over time, mainly due to such transmitters or 
carriers who show no symptoms. 
5. What makes the new COVID-19 outbreak different from the previous six coronaviruses? 
When something has happened six times within a system that is as complex as the Earth’s 
ecosystem, then it is no surprise that it would also happen for the seventh time. Another 
coronavirus is now trying to make itself at home in the human species. In this case, the 
primary reservoirs were probably bats again. We know this because the genetic sequence of 
this new coronavirus coincides with that found in hibernating bats in about 96 percent [4]. 
This time, instead of a civet, a smaller mammal or bird has probably served as coronavirus’ 
so-called transitional reservoir. 
It's possible that it was a pangolin, because in one of them, a coronavirus that matched to 
the human form by as much as 99% of the sequence was found, although this isn't 
completely definite either [5]. Sequence matching is not the only important factor when it 
comes to viral "jump" from animals to humans. What's also important is how many 
individuals in the species that serve as a transitional reservoir are infected and how often 
the species comes into contact with humans. Sometimes these factors are more important, 
so they can bridge the gap of 2-3% of the difference in genome sequence, because 
pangolins are a protected species and can't be eaten. 
Thus, in the Chinese province of Hubei, in the City of Wuhan, which has a population of 
eleven million, at around the end of 2019, the number of patients with an unusual and very 
dangerous type of pneumonia began to increase. Many of them had in common that they 
visited a particular fish market. It was soon discovered that this infectious disease was 
spreading very quickly. Each infected person managed to further infect as many as two to 
three people. Such a degree of infectivity is quite high and leads to rapid growth of the 
epidemic. We had the misfortune that the disease caused by the 7th coronavirus - COVID-19 
- apparently manages to spread even during the incubation period, possibly even by touch. 
This incubation period lasts about five days on average. It would be very tricky if it lasted 
longer, because the novel coronavirus would then have more time to spread from an 
already infected person to others. However, an incubation period of up to two weeks is not 
entirely unusual. Even rare cases who had incubation period of up to four weeks seem to be 
possible. During some of this time, the infected person can spread the virus before the 
onset of their first symptoms. If there are infected people who don’t develop symptoms, it 
will be really difficult to contain this pandemic until we develop a vaccine. In conclusion, 
infectivity, ie, the ability to move from the infected to the uninfected, seems to be 
significantly higher in COVID-19 than it was with SARS and MERS. As a trade-off, we now 
know that the COVID-19 case-fatality rate is significantly lower than that of SARS and MERS. 
6. What is the case-fatality rate among those infected with the COVID-19 epidemic, and 
why is there so much ambiguity about it in the media? 
In order to answer this rather complicated question, it must first be said that nowadays, the 
registered number of infected persons and the number of deaths can be monitored online 
[6]. When the registered number of infected people was divided by the number of deaths at 
the beginning of the pandemic, a figure of about 2% would be obtained [6]. From this alone, 
one could apparently conclude that - given that this is an entirely new coronavirus and 
nobody is immune to it - it will necessarily spread throughout the world and infect us all. If it 
kills 2 percent of all people, then it follows that out of a total of 7.5 billion people about 150 
million will necessarily die. It is difficult for anyone who is not a specialist in this field to 
understand how such an outcome can now be prevented, because a vaccine against this 
virus doesn’t yet exist, nor do medicines. 
The question of the case-fatality rate among those infected with COVID-19 exposed a 
general lack of epidemiological knowledge among the general public and in the media. From 
the very beginning of this pandemic, there were people who claimed that the new 
coronavirus was a disease milder than even the flu, but also those who believed it was 
significantly more dangerous. In recent days, this issue has finally caught the attention of all 
the world's media as the World Health Organisation reported “that about 3.4% of those 
infected with coronavirus have died” [7]. That sounded terrifying to the media and the 
public. 
But then the President of the USA, Mr Donald Trump, also made a public statement saying 
the number released by the WHO was “wrong.” He said that “he'd talked to people who 
knew something about it and that his impression was that the number was certainly below 
1%, if not significantly less” [8]. In my guest appearance on Sunday at 2 (an influential 
Croatian TV programme) on March 1st, I made an estimate of the case-fatality rate of 0.5-
1%, allowing for the possibility that it could even be smaller [9]. Namely, at this point we do 
not properly distinguish infection-fatality rate from case-fatality rate. So, once that insights 
into seroprevalence become available - may even bring this estimate further down. 
However, both Trump and WHO are actually right, each in their own way, which shows best 
and how difficult it is for many people to keep track of what is really going on because of 
their lack of knowledge of the epidemiology. 
In the beginning of every epidemic of a new virus, the virus has to “jump” over from animals 
to humans, and then from humans to humans. That can be quite difficult. Therefore, the 
virus will be more likely to successfully infect those with a weakened immune system, who 
will find it more difficult to reject it. Because of this, the first patients are often people who 
are either older or already have some underlying illnesses that make them more vulnerable. 
They end up in a hospital, where at that point no one suspects that pneumonia that they are 
experiencing may have an epidemic potential. 
Then, they infect other hospital patients and some healthcare professionals. The latter can 
then spread the disease to other patients in the hospital - mainly to those most susceptible, 
such as those ailing or immunocompromised, treated for serious illnesses or the elderly. 
This is the reason why the case-fatality rate among all COVID-19 patients was initially very 
high in Wuhan and later in Italy. Many people died of COVID-19 infections in hospitals and 
they were mostly very old and sick people [10]. 
In the meantime, the virus has started to spread among the general population - in the 
community and outside of hospitals. It has infected many people who are otherwise healthy 
and had a much better immune response. A large number of these people would have 
thought that they had a cold, or the flu, and perhaps even a more severe flu. They were just 
resting at home and letting those respiratory infections run their course. Considering that it 
was flu season in Wuhan at the time of the outbreak, and the media reported that a strange 
epidemic was causing many deaths in Wuhan's hospitals, it is quite likely that many Wuhan 
residents who were infected with the coronavirus stayed home and treated themselves. 
Few people would choose to go to the hospital to test whether their flu-like symptoms were 
caused by the novel coronavirus when a deadly epidemic was spreading there. Only the few 
who have struggled with fevers and symptoms for more than eight or nine days sought help 
from Wuhan hospitals. In China, there is typically no primary health care and family 
medicine as we know it, but there are large hospitals in their huge cities where patients 
report directly. That is the most likely explanation as to why the case-fatality rate among 
patients at Wuhan hospitals at the beginning of the epidemic was so frighteningly high. 
7. Is the infection of the most vulnerable in Wuhan hospitals early on in the epidemic the 
sole reason for the high initial case-fatality rate of COVID-19? 
It isn’t. The epidemic seemed even more dangerous at first, as it created a great deal of 
pressure on hospital intensive care units, which were unprepared for this infection. As a 
result, all severely ill patients could not receive intensive care. This further increased the 
case-fatality rate at the beginning of the epidemic. That is why the Chinese have started 
building the two new hospitals. They wanted to ensure a sufficient capacity to provide 
intensive care. Also, they needed to move all those infected with COVID-19 away from other 
seriously ill people who were sick from other diseases and at the highest risk of dying if they 
became infected. 
Based on this, it should be understood that the total number of those infected with COVID-
19 in Wuhan could have been much higher than what was confirmed by their health 
statistics. Specifically, only those with coronaviruses who were eventually admitted to the 
hospital were confirmed to be infected and were tested for the new virus there. They are by 
no means representative of all those infected with the new coronavirus in Wuhan. 
Therefore, the early estimates of case-fatality rates in Wuhan cannot be extrapolated even 
to all those with confirmed coronavirus infection in Wuhan, let alone would they be 
representative of the entire population of Wuhan. For those reasons it is wrong to look at 
the number of confirmed infected cases and the number of deaths on the Internet and 
divide those two numbers and draw any conclusions [11]. 
8. Why does the number of infected and deceased people on the Internet, which is 
constantly being updated, give a wrong impression about the case-fatality rate of COVID-
19? 
If all the reported deaths are divided by the total number of people with confirmed 
infection, then both the numerator and the denominator are wrong when it comes to 
calculating the actual case-fatality rate. Even deaths in the numerator would be wrong. This 
is because we monitor the confirmed infected and those who have died in real time. A great 
many infected people haven’t even had a chance to either recover or die, so the number of 
deaths in the numerator is an underestimate. 
Some of the people who are presently in intensive care are expected to die in several days, 
weeks, maybe even months. This is why the number of deaths that corresponds to the 
number presently infected will inevitably increase over time. Therefore, some future 
number of deaths, as the numerator, will increasingly correspond to the current number of 
registered infected persons, as the denominator. As a result, the case-fatality rate of 
“deaths among those with confirmed infection” will then no longer be 2 or 3 percent, but it 
may increase quite considerably over time - perhaps to 6-7 percent, or even more. 
Therefore, to simply say that “about 3.4% of those confirmed to have been infected so far 
have died” isn't really wrong in itself, which is what the World Health Organisation did. But 
it missed explaining that this case-fatality rate among confirmed infected people is quite 
unrepresentative of the mortality rate among all those who were infected [11]. The true 
rate should be much lower. It wouldn’t surprise me, as an epidemiologist, if it is up to ten 
times smaller, perhaps even more [11]. Depending on the actual, true number of infected 
people which should be used as a denominator, this could ultimately make COVID-19 a less 
deadly disease even than the common flu. 
9. Can we be certain that the true number of infected people is much higher than the 
number of confirmed infected people - is there any evidence for this? 
Given that the virus is new and unknown, this is a key question. Unfortunately, the 
possibility that this virus is quite different from other known viruses must also be allowed. It 
may be that the case-fatality rate among confirmed infected people is only 3 to 5 times 
higher than the infection-fatality rate, ie, the number of deaths among all infected people. 
So, it may not be ten or thirty times higher, as many epidemiologists would expect. The only 
thing we can be reasonably sure of is that the number of confirmed infected people wasn’t 
equal to the number of all infected people in Wuhan. The current global totals of confirmed 
infected and fatalities for COVID-19 are still largely determined by what happened in Wuhan 
at the beginning of the epidemic. This is because about two-thirds of cases worldwide still 
originate in Wuhan to this day [6]. 
That's why I've already explained on “Sunday at 2” TV programme that the case-fatality rate 
among those who were confirmed to be infected is not so important. It is only a subset of 
the patients with the most severe symptoms. We need to find out what is the case-fatality 
rate among all infected people. However, no one can know that at this time, because a 
random sample of at least 100,000 Wuhan residents would need to be tested for this. Then, 
the presence of antibodies against coronaviruses should be detected. This is how we 
measure “seroprevalence” [3]. 
This would allow us to estimate the number of people in Wuhan who got over the infection 
with the novel coronavirus without ever seeing a doctor. So far, no one has conducted these 
studies because the health system was preoccupied with diagnosing and treating the 
epidemic of COVID-19 in hospitals and struggled with it. It is now understood that during 
some days of the Wuhan outbreak there were not enough tests for all those who reported 
to hospitals with symptoms. 
However, additional lines of evidence are beginning to emerge. The first is the report of an 
international panel of experts who visited China [12]. They looked at the cases across China 
that were reported after February the 1st. At this point, the identification of those infected 
was significantly improved. Also, hospitals were better prepared for the epidemic. Case-
fatality rate of all cases that came under health surveillance and were tested dropped to 
about 0.7% [12]. 
For anyone who may remain sceptical of China's data, the first reports have recently been 
provided by South Korean authorities. That country has really led by example in proactively 
testing people, seeking out all those infected and their contacts, isolating them and treating 
them. In their analyses to date, case-fatality rate of all infected people has been slightly 
above 0.6% [13]. Both of those estimates could still increase, albeit not substantially, if they 
also included those who will likely die over time and are currently counted as infected. Still, 
at such a low case-fatality rate there should not be many additional deaths. In fact, it is 
more likely that many infected people remained undiagnosed and that the case-fatality rate 
is actually even lower [11]. 
Another interesting recent new source is the study of more than 1,000 hospitalized COVID-
19 patients who were followed up until the very end of the infection. This sample has been 
collected from more than 500 Chinese hospitals and the result was published recently in a 
leading medical journal [14]. This analysis quoted their overall case-fatality rate to be about 
1.4%. However, it did not include all those infected again, but rather those who requested 
hospital treatment [14]. Therefore, it should still be possible that the infection-fatality rate 
is at least two to three times smaller among all those who were infected with the novel 
coronavirus. 
Thus, it appears that data from very different and increasingly reliable sources are starting 
to converge to the values which I predicted on “Sunday at 2” TV show on March 1st, ie, 0.5-
1%. Because of all of the above, President of the USA Donald Trump was most likely right to 
say that this number should be closer to 1% and that he believes that it could even be well 
below 1% [8]. Everything we know about epidemiology and previous pandemics gives us 
hope that this should be the case. 
10. Can everyone in any given country become infected with a novel coronavirus? If so, 
would the case-fatality rate of 0.5-1% be applicable to the whole population? 
The virus will not succeed in infecting everyone for a number of reasons. Our first line of 
defence consists of anti-epidemic measures. All those who are experiencing symptoms and 
may be infected are being tested. All their contacts are also tested for the presence of the 
virus. Then, COVID-19 patients and all their contacts are being isolated [15]. 
These measures will significantly slow down the spread of the infectious disease and buy us 
time. It is of utmost importance that the number of patients with COVID-19 doesn’t increase 
too quickly. When the new cases emerge more slowly, the staff of national health care 
systems will be able to provide quality care to all patients. For the more severe cases they 
will also offer intensive care. In the absence of these measures, there would be an 
exponential increase in the number of infected people. This number would soon outgrow 
the capacity of the health system. Many people within countries are also protected by their 
geographical dispersion, ie, many people live in smaller towns and settlements. A large 
number of them will probably never be exposed to an infected person. 
Furthermore, as people become infected, develop COVID-19 and then get well, they should 
become immune to the virus. As a result, there will be fewer people the virus can still infect. 
At some point, the number of susceptible persons that infected people can spread 
coronavirus to will decrease substantially. At some point each infected person will, on 
average, pass the virus to less than one susceptible person. In time, this will eventually limit 
and stop the epidemic. That is the reason we vaccinate. Even if the virus infects some 
unvaccinated people, it will have very few options for further spread. Vaccinated people will 
already be immune to the virus and their bodies will react vigorously if the virus tries to 
enter [16]. Many processes in nature are self-limiting in a similar way - forest fires, stock 
market crashes and epidemics. 
Furthermore, the case-fatality rate should not be directly applicable to the entire population 
of a country to estimate the possible death toll. The first reason is that the virus mainly 
endangers the elderly, whose case-fatality rates are much higher. Young people and 
children rarely get unwell and their death rates are much, much lower. This is why age and 
sex structure of the population can diminish the potential of the virus to cause a very high 
number of COVID-19 casualties if the population is reasonably young [11]. 
11. Should we then fear the COVID-19 pandemic, and if so, how much? 
The situation should be taken seriously and people should be cautious, but there's no 
reason to be overly afraid. There is especially no reason to panic. Many people are afraid of 
this pandemic because they probably think that we are in a completely unfamiliar situation, 
so anything could happen. But it's unlikely that much could happen for which science could 
not find explanations and answers and the epidemiological services could not respond in a 
timely manner. It is unwise for a serious scientist to try to predict the spread of a completely 
new and unknown virus to the entire human population in the world, let alone to predict 
more specific outcomes. Still, we have in recent weeks collected enough information about 
the new COVID-19 virus for at least some predictions. 
If the new coronavirus spreads across any country over time and manages to circumvent the 
many prevention measures in place, the application of anti-epidemic measures should still 
limit its casualties to make them at least roughly comparable to the deaths from flu or road 
accidents in the same period. This means that some healthy caution is advisable. This 
caution is reasonable as long as it is on the same level as the fear you may feel when sitting 
in a car and preparing for a longer trip, or when you hear on the news that a more severe 
form of influenza has arrived. 
But many are wondering why the novel coronavirus attracts such a level of media attention. 
This is because flu has been a well-known disease for decades. It comes back every year and 
we have experience with its manifestations among many millions of patients worldwide. We 
know how to develop vaccines against flu in advance of its season [16]. We've even started 
to produce the first somewhat effective drugs and offer them on the market [17]. Unlike the 
flu, the new coronavirus is unknown to us. We should remain cautious so that we do not get 
unpleasantly surprised. At the same time, the most vulnerable among us, who are already 
seriously ill or very old, aren’t vaccinated, as is the case with the flu. This is why the new 
disease, COVID-19, can kill more easily. 
12. Is it clear that COVID-19 is a significantly more dangerous illness than the flu? 
This question has constantly been being raised since the beginning because many are 
looking at various figures without a deeper understanding of their background and are 
comparing the incomparable. 
First of all, the general public underestimates how serious and dangerous and serious the flu 
actually is - especially for the most vulnerable, the elderly and those who are already ill. 
Globally, influenza causes between 250,000 and 650,000 deaths annually, depending on the 
strain of the circulating virus [18]. Different strains can cause milder or more severe 
symptoms, and the virus mutates each year. However, we try to protect those most 
vulnerable before the flu season begins by vaccinating them. 
Therefore, the number of deaths from influenza is reduced by preventive health 
intervention, ie, vaccination. This cannot be done with the spread of COVID-19. This is the 
first reason why the flu seems less dangerous than COVID-19. However, it may not be much 
less dangerous inherently, especially during seasons when flu is more severe. It's just that 
we protect the most vulnerable. In addition, flu vaccinations make it more difficult for it to 
spread among the population because there are fewer options for it to transfer to the 
uninfected. Due to the slower spread, new cases emerge more slowly and the health care 
system has time to deal with them properly, especially if they require intensive care. 
Another reason is that the number of deaths directly from the flu is several times lower than 
the number of deaths that are indirectly caused by the flu. Influenza is often not cited as a 
direct cause in statistics on the causes of death, if it has merely led to the exacerbation of 
some of the long-present chronic, underlying disease. These chronic diseases are then cited 
as the primary cause of death, rather than influenza. Therefore, the actual role of influenza 
in annual mortality is often significantly underestimated. It can be several times higher 
when the causes of death are reclassified at the end of each year, based on the increase in 
deaths from chronic diseases during the flu season. 
The third reason for caution in comparing COVID-19 and flu is that we have a much better 
idea of the total number of people truly infected with the flu than we do about the novel 
coronavirus. This is because influenza is a disease that is typically managed within primary 
care, after which patients are referred to home care. Only the most serious cases of flu are 
referred to hospital. 
There is an obligation to report the total number of people infected with influenza in the 
population to the central registry, as well as for sick leave. This makes the denominator for 
case-fatality rate of influenza better known to us than we can estimate it for the novel 
coronavirus. COVID-19 has so far been diagnosed and treated exclusively in hospitals, where 
severe cases clustered. The early estimates of case-fatality rates for COVID-19 included 
patients suffering from hospital outbreaks, which affected the elderly, the sick and the 
immunocompromised. This is why those case-fatality rates are hardly comparable to a 
spread that would occur in the general population. 
From all of this, it should be concluded that case-fatality rates from influenza, as another 
very dangerous viral disease, have been mathematically reduced compared to the current 
reports of case-fatality rates for coronaviruses for the three reasons I mentioned. The first is 
because we vaccinate those most vulnerable to the flu. The second is that health statistics 
don’t assign the majority of flu deaths to influenza, but rather to the exacerbations of pre-
existing underlying illnesses such as cardiovascular diseases, diabetes, malignant tumours 
and others. The third is that the denominator we use to calculate case-fatality rates from 
influenza is much closer to the actual number of those infected, while the denominator for 
coronavirus is not yet known with sufficient certainty. From their experience with other 
respiratory viruses, epidemiologists know that all events in hospitals will dramatically over-
represent the most vulnerable. This is why those case-fatality rates should by no means be 
applied to the general population. 
However, lay members of the public cannot have a good sense of these nuances. That's why 
it is best to avoid comparisons between case-fatality rates for the flu and for the novel 
coronavirus until we learn more on the seroprevalence of the latter. The general public 
underestimates the risk of influenza for the three reasons mentioned above. They are also 
likely to overestimate the risk of the new coronavirus due to its intense media focus. If 
influenza infections and deaths were monitored in the same way each year, the public 
would realise how dangerous the flu really is and how reasonable it is to be vaccinated 
against it. 
Therefore, it still doesn't seem possible to me, at least at this stage of the pandemic, to 
decisively state which of the two diseases is inherently more dangerous to human beings or 
which will eventually cause more human deaths in 2020. Flu will cause fewer deaths 
because the most vulnerable will be vaccinated and health statistics will not properly 
attribute many indirect deaths to flu which really caused them. COVID-19, in turn, will cause 
fewer deaths due to epidemiological surveillance, the prevention of its spread and possible 
strict quarantine. It may also have seasonal characteristics and simply disappear with the 
arrival of late spring. 
13. Are such strict and massive quarantines justified? 
When we have no other means of defending ourselves against the new virus, all we can 
really do is retreat indoors and prevent the virus from “jumping” from infected to healthy 
individuals too quickly. People generally don't have an intuitive sense of exponential 
growth. If each newly infected person infects just one more person each day, the number of 
newly infected people will increase from 2 to 16 during the early phase, which doesn't seem 
like a big increase. 
A little later, it will jump to 1024 infected people from 128 over the next three days, and 
that doesn't sound so terrible either. But there will also come four days in which the 
number of newly infected people will increase from 100,000 to 800,000. 
When China realised that the COVID-19 epidemic was out of control and that it already 
entered this explosive phase, the authorities immediately cut off Wuhan and then fifteen 
other cities from the rest of the country. In addition, the authorities ordered that the 
population within these cut-off areas stay in their apartments and not leave. It was an 
unprecedented measure in human history - tens of millions of people were quarantined for 
weeks. Everything stopped [12]. 
However, this measure produced excellent results and China could keep its death toll below 
5,000, although the epidemic caught them unprepared and the virus spread to all Chinese 
provinces. A recent report from the World Health Organisation's commission made up of 25 
international experts visiting China concluded the following: 
“China’s bold approach to contain the rapid spread of this new respiratory pathogen has 
changed the course of a rapidly escalating and deadly epidemic”. Faced with an unknown 
virus, “...China has rolled out perhaps the most ambitious, agile, and aggressive disease 
containment effort in history”. [12] 
14. What happened on the Diamond Princess ship, which is also isolated? It appears to 
have a case-fatality rate of more than 1% for those infected. Isn't that very informative for 
scientists? 
This may be because, on these large ships, people are mostly older. One should look very 
closely at the age and gender structure of passengers, which would tell us more about the 
final outcome. It is also quite possible that a mutated version of the virus, which is 
somewhat more dangerous, could have entered such a "pocket". Such isolated groups can 
always emerge and the disease may actually run a more severe course there. This is 
possible, but not very likely. Also, this case-fatality rate should not be extrapolated to the 
entire country for the same reason. 
Once the virus begins to spread through the entire human species, it will continue to 
mutate. It will try to adapt to humans as quickly as possible. According to previous 
epidemiological experiences, many of those mutations should make it less dangerous for 
human health, as this would lead to a better adaptation. However, some random mutations 
could make it more dangerous to us. This is why we need to be on our guard until we get 
better acquainted with the virus and the pandemic is over. It is unlikely that the novel 
coronavirus will mutate to become significantly more dangerous than it is now, but we will 
only be able to assert that with certainty when the pandemic is over. 
15. What is happening in Italy and Iran? Does COVID-19 behave differently in those two 
countries than it does in others? Could the development of a mutated, more dangerous 
variant of the virus explain the differences? 
These are very difficult questions to answer until we get more quality data from both 
countries. In principle, it is possible that the first entry of the virus into a new country may 
be through an infected person in whom the virus has mutated into a more severe form. If all 
further cases arise from that mutant, then the situation in those countries may initially 
seem more difficult than elsewhere. In population genetics this development is known as 
the so-called “founder effect” [19]. However, patterns of spread and case-fatality rates in 
both countries may also have many different explanations. 
The reason why the death toll among infected people in Italy appears to be very high is 
because the disease is spreading in small-town hospitals and elderly care homes which were 
completely unprepared for the epidemic. The elderly and infirm are at much greater risk of 
dying if they become infected. 
Case-fatality rates in hospital outbreaks where older, sick and immunocompromised people 
are affected will be much higher than those in the community, among younger and healthy 
people. Among the first several hundred deaths in Italy, almost all people were over 60 
years of age and had underlying illnesses [20]. That is why the case-fatality rate seems so 
high there, but it is not representative of the entire population. A harsh flu season would 
probably have done similar damage if people had not been vaccinated against it. But it's 
also possible that there are many more cases in the population than previously thought 
because the virus has been spreading for a long time. In Iran, however, the situation is 
unclear so far. The most likely explanation, too, is that there are already significantly more 
cases of infection among the population than it was thought initially. 
16. Is it possible that coronavirus may surprise us and ultimately prove significantly more 
dangerous than seasonal influenza? Could it perhaps cause more than one million deaths 
in the world, or even several million? 
If COVID-19 proves to be significantly more dangerous than seasonal influenza, then one 
million deaths worldwide could indeed be expected, perhaps significantly more. 
Unfortunately, such a scenario is still possible in principle with a virus that is new and 
unknown to us, for a variety of reasons. Because of this, all experts in the field, including 
myself, are constantly urging people to take caution, but without the unnecessary panic. 
In which scenarios could the situation become much more difficult? Firstly, most 
epidemiologists, based on their experience with previous epidemics and pandemics, expect 
the COVID-19 case-fatality rate to fall below 1% when the total death toll is divided by a 
better estimate of the total number of infected people. However, the virus is new, so it's 
possible in principle for this specific virus that the number of infected individuals who are 
not confirmed through testing may not be as large as epidemiologists would expect. This 
would come as a surprise to science and would indicate a different nature of this virus. 
The new coronavirus causing COVID-19 is somewhat similar to that caused by SARS. The 
SARS pathogen, however, had a much higher case-fatality rate. If the total population 
infected by the novel coronavirus is found to be higher than the registered infected 
population by only two or three times, and not by e.g. ten times or more, then the case-
fatality rate of those infected with COVID-19 could be significantly higher than the flu. 
Combined with the lack of an available vaccine, in such a case it would lead to a significantly 
higher number of deaths than the flu. However, such an occurrence should still be 
prevented by measures of isolation of the patients and their contacts, as well as by 
quarantines, which aren't applied in the case of flu. We also hope that with the winter 
ending and the new seasons arriving, seasonality would slow down or completely hinder the 
further spread of the virus. 
Furthermore, the virus could spread to infected people in some of its more dangerous 
forms, as well as in milder forms. Previous experiences with epidemics have shown that 
mutation into milder forms is more likely, but mutation into more dangerous forms, or 
those that are more easily spread, isn't impossible either [3]. In some countries, such a 
variant would increase the case-fatality rate locally compared to other countries or 
accelerate infection. 
This would put their health systems in a really difficult situation as intensive care units 
would soon become overburdened. With poorer care available, case-fatality rate of all those 
infected would increase further, with the likely collapse of part of the health system. It's 
also a very tricky scenario in which many healthcare professionals would become infected 
over time in providing care to patients, which would make the situation worse. 
Therefore, currently, perhaps the most important citizens of any country are healthcare 
professionals who work in hospitals for infectious diseases, especially in their intensive care 
units. They should be protected not only from work overload, but also from coronavirus 
infection by their patients. With the increasing number of infected people with severe forms 
of disease, the demand for quality intensive care, respirators and ECMO devices for 
extracorporeal oxygen enrichment will become the “bottleneck” of the health care system. 
The same is true for healthy and well rested doctors and nurses in these wards. Those parts 
of the health system should be amplified and further strengthened before they come under 
increased pressure. 
The worst-case scenario imaginable right now is the entry of some more dangerous, 
mutated version of coronavirus into one of the very poor countries in the world with a 
dysfunctional health system. Such countries cannot implement satisfactory quality 
epidemiological surveillance measures. Then, a more dangerous version of the virus would 
likely infect a larger percentage of the country's population relatively quickly. Panic would 
ensue, probably also a black market for the transport of migrants to other countries. Then, a 
more severe variant of COVID-19 would start to expand uncontrollably and in a whole new 
way. 
In the event of any of these unfavourable developments, all of which are unfortunately 
possible though not likely, an entirely new protection strategy would be required. Each 
country will have its own approach. When the death toll in each of the affected countries 
begins to rise so much as to cause fear among the population, people will become 
increasingly willing to undertake much stricter epidemiological measures. In such a case, an 
increasing number of countries will resort to a solution that has proven effective in Wuhan - 
ie, declaring large, very strict quarantines. It is essential to buy time in such quarantines so 
that health systems don't become overburdened. We should then anticipate the end of 
winter and hope that there would be evidence of possible seasonality of this virus. It may 
then begin to spread in a weakened manner or disappear altogether, at least until next 
winter. 
17. With these reasons for caution and a number of adverse scenarios, is there any reason 
for possible optimism? 
There are at least several reasons for optimism. First of all, epidemiological surveillance and 
“first lines of defence” are currently in place throughout the European Union. If they work 
well in most countries, it’s possible that their outbreaks will be controlled and would not 
enter a phase of exponential growth in the number of infected cases. In the most favourable 
scenario, with this retention, this novel coronavirus would show seasonality. Then, it would 
gradually disappear from circulation among humans with changes in nature characteristic of 
late spring and summer [3]. However, this is the most favourable scenario, in which the final 
death toll would be much lower than that already caused by the flu this year. 
However, if the front line of defence and epidemiological surveillance is broken through by 
the virus, then governments will resort to strict measures to ban assemblies and organise 
quarantines, as the Chinese did. Several models done in recent weeks indicate that strict 
quarantine should completely suppress the spread of this coronavirus within up to three 
months [21]. This is exactly what we've already seen in China. That's why it seems that one 
great positive lesson of this pandemic is that humanity today would be able to survive even 
more dangerous infectious diseases than COVID-19 with strict quarantine, in which people 
would remain until scientists developed vaccines. In this unusual situation this answer has 
been revealed to us all. 
Finally, the tireless work of numerous scientists currently testing over a hundred drugs 
against this virus, as well as at least eleven experimental vaccines, should be noted [22]. It is 
not impossible that some existing medicines may show some effect and be repurposed to 
treat COVID-19. Also, vaccines should become available over time. In this unusual situation, 
emergence of an effective drug or a vaccine could make a sudden and important difference. 
18. Apart from the apparent effectiveness of quarantine in China, can we draw any further 
lessons from this pandemic? 
We should try to find something good in all the bad things that seem to be happening. Many 
people may finally realise how dangerous flu is. More of them may start getting vaccinated 
against it. Each year, the flu kills between 250,000 and 650,000 people worldwide [18]. 
In China, which is one-sixth of the world's population, the death toll from COVID-19 could be 
stopped below 5,000 by the Wuhan quarantine. If all other countries could implement anti-
epidemic measures like China, then the death toll from COVID -19 could be at most six times 
higher, ie, up to 30,000. That would be ten times fewer deaths than the total number of 
deaths caused annually by seasonal influenza. Unfortunately, many countries will not be 
able to follow China's example closely and will have uncontrolled outbreaks if the warmer 
season doesn't stop the spread of the virus. 
Furthermore, if the virus continues to spread throughout 2020, it will demonstrate in a very 
cruel way how well the leadership and public health systems of individual countries 
function. It will be possible to produce performance charts for each country in controlling 
this new infectious disease, given the population size and age structure. These will be very 
important lessons to learn in preparation for a future pandemic, which could be even more 
dangerous. 
Additionally, viruses generally spread by contact. This means that it's good to be reminded 
that hands should be regularly and properly washed during epidemics and touching surfaces 
that many people touch should be avoided (knobs, handrails, ATMs). Shaking hands should 
also be avoided and we should keep at least two steps away from people who have 
symptoms of respiratory infections. It's also advisable to regularly ventilate all living 
quarters. It's also helpful to strengthen personal immunity with sufficient sleep, exercise 
and good nutrition. 
19. Are there any real surprises for science related to this pandemic, at least for now? 
We all hope at this point (March 7th, 2020) that there would be very few. I explained why it 
is no surprise that after the previous six coronaviruses, the seventh has now also managed 
to infect humans. Nor is its spread rate a surprise, as there are both more and less infectious 
respiratory viruses [3]. It would be somewhat surprising for epidemiologists if the total 
number of infected people in the population wasn't significantly higher than the number of 
registered infected people. In such occurrence, case-fatality rate would indeed become 
significantly higher than that of the flu. We should continue to await the information of 
well-conducted studies on this key question. 
Perhaps the biggest surprises so far have been related to the clinical course of COVID-19 
rather than its epidemiology. For now, clinicians in China have reported that registered 
infected people report to the hospital rather late, on average after as many as 9-12 days of 
home care [23]. This may reflect their fear of being admitted to the hospital during an 
epidemic, but it may also be an interesting feature of an illness with slow development in 
comparison to other respiratory infections. Furthermore, fever doesn't appear to always 
accompany other symptoms of the disease in the first few days, making it difficult to 
identify possibly contagious cases by controlling people’s temperatures [23]. 
The media has also reported on the possible return of the virus after suffering from the 
infection in some cases [24]. For now, it's hard to know how common these cases are, and 
how many exceptions there are. It is often wise to rest well after many viral respiratory 
infections to allow the body to recover after the infection has ended. It is unknown whether 
this infection can return if the immune system has not completely removed the virus from 
the body. But with all new and unknown viruses such surprises are possible, so one should 
be careful until the pandemic is over. 
20. What are the closing messages at the end of February 2020? 
In all the answers provided in this editorial I endeavoured to convey the most likely scientific 
explanations for the abundant information that is published about COVID-19 in the 
domestic and international media. Over time, some of the likely scientific explanations may 
need to be modified in the light of new information. One shouldn't forget that this is a new 
and unknown virus. Therefore, surprises and deviations from the expected scenarios are in 
principle possible. That's why I emphasise that caution is needed, but not panic. The 
community of scientists and health experts will continue to closely monitor the further 
development of the pandemic. 
Obviously, we need to prepare for a very serious flu-like illness against which no-one will be 
able to be vaccinated against for quite a while. Therefore, elderly people and those with 
underlying illnesses should be extremely careful because the infection is the most 
dangerous for them. Having gained our first knowledge of COVID-19, we now need to 
concentrate on preventing the spread of the virus and buying time until the arrival of 
warmer days. Then, we might be lucky enough to see the virus slowly disappearing due to 
seasonality. Unfortunately, we can't know that right now. From everything written here, it 
should be understood that all measures of active searching and the isolation of affected 
patients and their contacts are justified. 
These also include bans on gathering together larger groups of people, as well as possible 
quarantine if the epidemic starts to elude epidemiological control. Particularly, older people 
should be looked after because the probability of a bad outcome increases significantly with 
age. In addition, those with heart disease, diabetes, or undergoing cancer treatment should 
take special care. 
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